These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15773958)

  • 1. Potential value of high-dose mizoribine as rescue therapy for ongoing acute humoral rejection.
    Liu D; Kobayashi T; Nagasaka T; Yokoyama I; Ma Y; Miwa Y; Kuzuya T; Morozumi K; Oikawa T; Shimano Y; Takeuchi O; Uchida K; Nakao A
    Transpl Int; 2005 Apr; 18(4):401-7. PubMed ID: 15773958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic treatment of antibody-mediated rejection with high-dose mizoribine and pharmacokinetic study.
    Liu D; Kobayashi T; Nagasaka T; Miwa Y; Ma Y; Yokoyama I; Kuzuya T; Oikawa T; Morozumi K; Uchida K; Nakao A
    Transpl Int; 2007 Apr; 20(4):365-70. PubMed ID: 17326777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure caused by hyperuremic acidemia in ABO-incompatible kidney transplant maintained with cyclosporine and high-dose mizoribine: a case report.
    Akioka K; Masuda K; Harada S; Nakamura T; Okugawa K; Nakano K; Osaka Y; Tsuchiya K; Sako H
    Transplant Proc; 2013 Sep; 45(7):2815-8. PubMed ID: 24034056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination effect of mycophenolate mofetil with mizoribine on cell proliferation assays and in a mouse heart transplantation model.
    Shimmura H; Tanabe K; Habiro K; Abe R; Toma H
    Transplantation; 2006 Jul; 82(2):175-9. PubMed ID: 16858279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences of high-dose mizoribine as antimetabolite immunosuppressants for kidney transplantation.
    Nakamura N; Mikami H; Matsuoka H; Irie S; Abe Y; Sasatomi Y; Ogawara S; Saitoh T; Tanaka M
    Transplant Proc; 2012 Jan; 44(1):150-3. PubMed ID: 22310602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective use of mycophenolate mofetil in renal transplant patients in Indian scenario.
    Srivastava A; Singh V; Kumar A; Sharma RK; Gupta A
    Transplant Proc; 2004 Sep; 36(7):2060-4. PubMed ID: 15518746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revival of effective and safe high-dose mizoribine for the kidney transplantation.
    Sugitani A; Kitada H; Ota M; Yoshida J; Doi A; Hirakata H; Tanaka M
    Clin Transplant; 2006; 20(5):590-5. PubMed ID: 16968484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
    Boratyńska M; Banasik M; Patrzałek D; Klinger M
    Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil.
    Sun Q; Liu ZH; Cheng Z; Chen J; Ji S; Zeng C; Li LS
    Kidney Int; 2007 Jan; 71(1):24-30. PubMed ID: 16969384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective trial of steroid cessation after renal transplantation in pediatric patients treated with cyclosporine and mizoribine.
    Motoyama O; Hasegawa A; Ohara T; Hattori M; Kawaguchi H; Takahashi K; Kamiyama Y; Nakai H; Shishido S; Ogawa O; Kawamura T; Tsuzuki K; Oshima S
    Pediatr Transplant; 1997 Aug; 1(1):29-36. PubMed ID: 10084784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
    Kovac D; Kotnik V; Kandus A
    Transplant Proc; 2005 Dec; 37(10):4230-4. PubMed ID: 16387086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mizoribine in renal transplantation.
    Tsuzuki K
    Pediatr Int; 2002 Apr; 44(2):224-31. PubMed ID: 11896891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience of mycophenolate mofetil in the treatment of chronic allograft nephropathy in kidney transplantation: three-year follow-up.
    Chu SH; Wu CT; Chou CC; Chen Y; Liu KL; Chiang YJ
    Transplant Proc; 2004 Sep; 36(7):2073-5. PubMed ID: 15518750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil.
    Liu M; Ji SM; Tang Zh; Ji DX; Chen HP; Liu ZH; Li LS
    Transplant Proc; 2004 Sep; 36(7):2101-3. PubMed ID: 15518760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
    Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
    Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.